A conditional model reveals that induction of hepatocyte nuclear factor-1alpha in Hnf1alpha-null mutant beta-cells can activate silenced genes postnatally, whereas overexpression is deleterious
- PMID: 16873682
- DOI: 10.2337/db05-1534
A conditional model reveals that induction of hepatocyte nuclear factor-1alpha in Hnf1alpha-null mutant beta-cells can activate silenced genes postnatally, whereas overexpression is deleterious
Abstract
Humans with heterozygous loss-of-function mutations in the hepatocyte nuclear factor-1alpha (HNF1alpha) gene develop beta-cell-deficient diabetes (maturity-onset diabetes of the young type 3), indicating that HNF1alpha gene dosage is critical in beta-cells. However, whether increased HNF1alpha expression might be beneficial or deleterious for beta-cells is unknown. Furthermore, although it is clear that HNF1alpha is required for beta-cell function, it is not known whether this role is cell autonomous or whether there is a restricted developmental time frame for HNF1alpha to elicit gene activation in beta-cells. To address this, we generated a tetracycline-inducible mouse model that transcribes HNF1alpha selectively in beta-cells in either wild-type or Hnf1alpha-null backgrounds. Short-term induction of HNF1alpha in islets from adult Hnf1alpha(-/-) mice that did not express HNF1alpha throughout development resulted in the activation of target genes, indicating that HNF1alpha has beta-cell-autonomous functions that can be rescued postnatally. However, transgenic induction throughout development, which inevitably resulted in supraphysiological levels of HNF1alpha, strikingly caused a severe reduction of cellular proliferation, increased apoptosis, and consequently beta-cell depletion and diabetes. Thus, HNF1alpha is sensitive to both reduced and excessive concentrations in beta-cells. This finding illustrates the paramount importance of using the correct concentration of a beta-cell transcription factor in both gene therapy and artificial differentiation strategies.
Similar articles
-
Transcriptional regulation of human and mouse organic anion transporter 1 by hepatocyte nuclear factor 1 alpha/beta.J Pharmacol Exp Ther. 2008 Feb;324(2):784-90. doi: 10.1124/jpet.107.128249. Epub 2007 Nov 20. J Pharmacol Exp Ther. 2008. PMID: 18029548
-
Regulation of tissue-specific expression of the human and mouse urate transporter 1 gene by hepatocyte nuclear factor 1 alpha/beta and DNA methylation.Mol Pharmacol. 2007 Dec;72(6):1619-25. doi: 10.1124/mol.107.039701. Epub 2007 Sep 13. Mol Pharmacol. 2007. PMID: 17855651
-
Germline hepatocyte nuclear factor 1alpha and 1beta mutations in renal cell carcinomas.Hum Mol Genet. 2005 Mar 1;14(5):603-14. doi: 10.1093/hmg/ddi057. Epub 2005 Jan 13. Hum Mol Genet. 2005. PMID: 15649945
-
Distinct roles of HNF1beta, HNF1alpha, and HNF4alpha in regulating pancreas development, beta-cell function and growth.Endocr Dev. 2007;12:33-45. doi: 10.1159/000109603. Endocr Dev. 2007. PMID: 17923767 Review.
-
Minireview: pharmacogenetics and beyond: the interaction of therapeutic response, beta-cell physiology, and genetics in diabetes.Endocrinology. 2006 Jun;147(6):2657-63. doi: 10.1210/en.2006-0152. Epub 2006 Mar 23. Endocrinology. 2006. PMID: 16556760 Review.
Cited by
-
Transgenic overexpression of the transcription factor Nkx6.1 in β-cells of mice does not increase β-cell proliferation, β-cell mass, or improve glucose clearance.Mol Endocrinol. 2011 Nov;25(11):1904-14. doi: 10.1210/me.2011-1010. Epub 2011 Sep 29. Mol Endocrinol. 2011. PMID: 21964593 Free PMC article.
-
Macrosomia and hyperinsulinaemic hypoglycaemia in patients with heterozygous mutations in the HNF4A gene.PLoS Med. 2007 Apr;4(4):e118. doi: 10.1371/journal.pmed.0040118. PLoS Med. 2007. PMID: 17407387 Free PMC article.
-
Hepatic nuclear factor 1alpha (HNF1alpha) dysfunction down-regulates X-box-binding protein 1 (XBP1) and sensitizes beta-cells to endoplasmic reticulum stress.J Biol Chem. 2011 Sep 16;286(37):32300-12. doi: 10.1074/jbc.M111.247866. Epub 2011 Jul 22. J Biol Chem. 2011. PMID: 21784843 Free PMC article.
-
Early loss of mammalian target of rapamycin complex 1 (mTORC1) signalling and reduction in cell size during dominant-negative suppression of hepatic nuclear factor 1-alpha (HNF1A) function in INS-1 insulinoma cells.Diabetologia. 2009 Jan;52(1):136-44. doi: 10.1007/s00125-008-1168-8. Epub 2008 Oct 24. Diabetologia. 2009. PMID: 18949455
-
Hnf1alpha (MODY3) controls tissue-specific transcriptional programs and exerts opposed effects on cell growth in pancreatic islets and liver.Mol Cell Biol. 2009 Jun;29(11):2945-59. doi: 10.1128/MCB.01389-08. Epub 2009 Mar 16. Mol Cell Biol. 2009. PMID: 19289501 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases